Decreased costs and retained QoL due to the 'PACE Steps to Success' intervention in LTCFs: cost-effectiveness analysis of a randomized controlled trial.
Cost-benefit analysis
Nursing homes
Palliative care
Teaching
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
22 09 2020
22 09 2020
Historique:
received:
07
04
2020
accepted:
24
07
2020
entrez:
22
9
2020
pubmed:
23
9
2020
medline:
12
2
2021
Statut:
epublish
Résumé
The number of residents in long-term care facilities (LTCFs) in need of palliative care is growing in the Western world. Therefore, it is foreseen that significantly higher percentages of budgets will be spent on palliative care. However, cost-effectiveness analyses of palliative care interventions in these settings are lacking. Therefore, the objective of this paper was to assess the cost-effectiveness of the 'PACE Steps to Success' intervention. PACE (Palliative Care for Older People) is a 1-year palliative care programme aiming at integrating general palliative care into day-to-day routines in LTCFs, throughout seven EU countries. A cluster RCT was conducted. LTCFs were randomly assigned to intervention or usual care. LTCFs reported deaths of residents, about whom questionnaires were filled in retrospectively about resource use and quality of the last month of life. A health care perspective was adopted. Direct medical costs, QALYs based on the EQ-5D-5L and costs per quality increase measured with the QOD-LTC were outcome measures. Although outcomes on the EQ-5D-5L remained the same, a significant increase on the QOD-LTC (3.19 points, p value 0.00) and significant cost-savings were achieved in the intervention group (€983.28, p value 0.020). The cost reduction mainly resulted from decreased hospitalization-related costs (€919.51, p value 0.018). Costs decreased and QoL was retained due to the PACE Steps to Success intervention. Significant cost savings and improvement in quality of end of life (care) as measured with the QOD-LTC were achieved. A clinically relevant difference of almost 3 nights shorter hospitalizations in favour of the intervention group was found. This indicates that timely palliative care in the LTCF setting can prevent lengthy hospitalizations while retaining QoL. In line with earlier findings, we conclude that integrating general palliative care into daily routine in LTCFs can be cost-effective. ISRCTN14741671 .
Sections du résumé
BACKGROUND
The number of residents in long-term care facilities (LTCFs) in need of palliative care is growing in the Western world. Therefore, it is foreseen that significantly higher percentages of budgets will be spent on palliative care. However, cost-effectiveness analyses of palliative care interventions in these settings are lacking. Therefore, the objective of this paper was to assess the cost-effectiveness of the 'PACE Steps to Success' intervention. PACE (Palliative Care for Older People) is a 1-year palliative care programme aiming at integrating general palliative care into day-to-day routines in LTCFs, throughout seven EU countries.
METHODS
A cluster RCT was conducted. LTCFs were randomly assigned to intervention or usual care. LTCFs reported deaths of residents, about whom questionnaires were filled in retrospectively about resource use and quality of the last month of life. A health care perspective was adopted. Direct medical costs, QALYs based on the EQ-5D-5L and costs per quality increase measured with the QOD-LTC were outcome measures.
RESULTS
Although outcomes on the EQ-5D-5L remained the same, a significant increase on the QOD-LTC (3.19 points, p value 0.00) and significant cost-savings were achieved in the intervention group (€983.28, p value 0.020). The cost reduction mainly resulted from decreased hospitalization-related costs (€919.51, p value 0.018).
CONCLUSIONS
Costs decreased and QoL was retained due to the PACE Steps to Success intervention. Significant cost savings and improvement in quality of end of life (care) as measured with the QOD-LTC were achieved. A clinically relevant difference of almost 3 nights shorter hospitalizations in favour of the intervention group was found. This indicates that timely palliative care in the LTCF setting can prevent lengthy hospitalizations while retaining QoL. In line with earlier findings, we conclude that integrating general palliative care into daily routine in LTCFs can be cost-effective.
TRIAL REGISTRATION
ISRCTN14741671 .
Identifiants
pubmed: 32957971
doi: 10.1186/s12916-020-01720-9
pii: 10.1186/s12916-020-01720-9
pmc: PMC7507669
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
258Subventions
Organisme : Seventh Framework Programme
ID : 6031111
Pays : International
Investigateurs
Paula Andreasen
(P)
Ilona Barańska
(I)
Catherine Bassal
(C)
Danni Collingridge Moore
(DC)
Harriet Finne-Soveri
(H)
Katherine Froggatt
(K)
Teija Hammar
(T)
Rauha Heikkilä
(R)
Jo Hockley
(J)
Elisabeth Honinx
(E)
Hein van Hout
(H)
Violetta Kijowska
(V)
Maud Ten Koppel
(M)
Outi Kuitunen-Kaija
(O)
Suvi Leppäaho
(S)
Federica Mammarella
(F)
Martina Mercuri
(M)
Rose Miranda
(R)
Emilie Morgan de Paula
(EM)
Nele Van Den Noortgate
(N)
Mariska Oosterveld-Vlug
(M)
Agnieszka Pac
(A)
H Roeline W Pasman
(HRW)
Sophie Pautex
(S)
Sheila Payne
(S)
Ruth Piers
(R)
Lara Pivodic
(L)
Paola Rossi
(P)
Katarzyna Szczerbińska
(K)
Ivan Segat
(I)
Jenny T van der Steen
(JT)
Agata Stodolska
(A)
Marc Tanghe
(M)
Références
J Am Med Dir Assoc. 2013 Jul;14(7):485-92
pubmed: 23523319
Palliat Med. 2014 Feb;28(2):151-7
pubmed: 23698452
Health Econ. 2018 Jan;27(1):7-22
pubmed: 28833869
Health Aff (Millwood). 2017 Jul 1;36(7):1211-1217
pubmed: 28679807
Arch Intern Med. 2009 Mar 9;169(5):480-8
pubmed: 19273778
Implement Sci. 2016 Jul 16;11:94
pubmed: 27422011
J Palliat Med. 2000 Fall;3(3):287-300
pubmed: 15859670
Value Health. 2020 May;23(5):642-648
pubmed: 32389230
Health Econ. 2002 Jul;11(5):415-30
pubmed: 12112491
Palliat Med. 2018 Feb;32(2):447-465
pubmed: 28655289
Int J Geriatr Psychiatry. 2004 Nov;19(11):1026-34
pubmed: 15481077
Value Health. 2018 Jan;21(1):49-56
pubmed: 29304940
Palliat Med. 2019 Dec;33(10):1282-1298
pubmed: 31368855
J Pain Symptom Manage. 2009 Jul;38(1):4-10
pubmed: 19615621
BMC Res Notes. 2016 Apr 26;9:237
pubmed: 27112921
J Pain Symptom Manage. 2013 Feb;45(2):223-34
pubmed: 22917717
Qual Life Res. 2012 May;21(4):671-84
pubmed: 21814875
Cost Eff Resour Alloc. 2013 Mar 25;11(1):6
pubmed: 23531194
Int Psychogeriatr. 2017 Apr;29(4):569-581
pubmed: 28088926
J Pain Symptom Manage. 2011 Dec;42(6):852-63
pubmed: 21620642
JAMA Intern Med. 2020 Feb 1;180(2):233-242
pubmed: 31710345
BMC Palliat Care. 2018 Mar 12;17(1):47
pubmed: 29530091
JAMA. 2016 Nov 22;316(20):2104-2114
pubmed: 27893131
Stat Med. 2000 Dec 15;19(23):3219-36
pubmed: 11113956
Palliat Med. 2014 Dec;28(10):1167-96
pubmed: 24866758
J Am Med Dir Assoc. 2016 Apr 1;17(4):284-93
pubmed: 26861748
Value Health. 2009 Nov-Dec;12(8):1194-200
pubmed: 19695009
Health Econ. 2008 Jun;17(6):667-70
pubmed: 18457341
Br J Cancer. 1999 Sep;81(1):87-94
pubmed: 10487617
J Clin Epidemiol. 2014 Sep;67(9):1035-43
pubmed: 24837298
J Palliat Med. 2016 Aug;19(8):842-8
pubmed: 27167637
Palliat Med. 2017 Apr;31(4):306-322
pubmed: 28190374
N Engl J Med. 2010 Aug 19;363(8):733-42
pubmed: 20818875
Palliat Med. 2014 Sep;28(8):1000-25
pubmed: 24651708
Arch Intern Med. 2008 Sep 8;168(16):1747-54
pubmed: 18779461
J Am Med Dir Assoc. 2015 Jun 1;16(6):515-20
pubmed: 25805625
Cochrane Database Syst Rev. 2017 Jun 12;6:CD011129
pubmed: 28603881
JAMA. 2008 Apr 9;299(14):1698-709
pubmed: 18398082
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD007760
pubmed: 23744578
J Am Med Dir Assoc. 2015 Jan;16(1):86.e1-7
pubmed: 25481748
Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):88-94
pubmed: 23632265
JAMA. 2004 Jan 7;291(1):88-93
pubmed: 14709580
JAMA. 2000 Nov 15;284(19):2476-82
pubmed: 11074777
Arch Intern Med. 2008 Sep 8;168(16):1783-90
pubmed: 18779466
Palliat Med. 2014 Feb;28(2):130-50
pubmed: 23838378